Literature DB >> 15227471

Lipids, atherosclerosis, and restenosis after percutaneous transluminal coronary angioplasty.

J J Ferguson1, J T Willerson.   

Abstract

Entities:  

Year:  1992        PMID： 15227471      PMCID： PMC325018     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  56 in total

1.  OBSERVATIONS CONCERNING THE EVOLUTION OF ATHEROSCLEROSIS IN THE RABBIT AFTER CESSATION OF CHOLESTEROL FEEDING.

Authors:  M FRIEDMAN; S O BYERS
Journal:  Am J Pathol       Date:  1963-09       Impact factor: 4.307

2.  ABOLISHMENT OF ALIMENTARY LIPEMIA FOLLOWING INJECTION OF HEPARIN.

Authors:  P F Hahn
Journal:  Science       Date:  1943-07-02       Impact factor: 47.728

3.  The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial.

Authors:  P Leren
Journal:  Acta Med Scand Suppl       Date:  1966

4.  Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

Authors:  M H Frick; O Elo; K Haapa; O P Heinonen; P Heinsalmi; P Helo; J K Huttunen; P Kaitaniemi; P Koskinen; V Manninen
Journal:  N Engl J Med       Date:  1987-11-12       Impact factor: 91.245

5.  Regression of peripheral atherosclerosis during therapy with high doses of nicotinic acid.

Authors:  C R Ost; S Sténson
Journal:  Scand J Clin Lab Invest Suppl       Date:  1967

6.  Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men.

Authors:  I Hjermann; K Velve Byre; I Holme; P Leren
Journal:  Lancet       Date:  1981-12-12       Impact factor: 79.321

7.  Platelet function, thromboxane formation and blood pressure control during supplementation of the Western diet with cod liver oil.

Authors:  R Lorenz; U Spengler; S Fischer; J Duhm; P C Weber
Journal:  Circulation       Date:  1983-03       Impact factor: 29.690

8.  Inhibition of atherosclerosis by cod-liver oil in a hyperlipidemic swine model.

Authors:  B H Weiner; I S Ockene; P H Levine; H F Cuénoud; M Fisher; B F Johnson; A S Daoud; J Jarmolych; D Hosmer; M H Johnson
Journal:  N Engl J Med       Date:  1986-10-02       Impact factor: 91.245

9.  Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.

Authors:  J F Brensike; R I Levy; S F Kelsey; E R Passamani; J M Richardson; I K Loh; N J Stone; R F Aldrich; J W Battaglini; D J Moriarty
Journal:  Circulation       Date:  1984-02       Impact factor: 29.690

10.  Further studies on the reversibility of serum sickness cholesterol-induced atherosclerosis.

Authors:  M Van Winkle; L Levy
Journal:  J Exp Med       Date:  1970-11       Impact factor: 14.307
View more
  2 in total

1.  High rate of in-stent restenosis after coronary intervention in carriers of the mutant mannose-binding lectin allele.

Authors:  Zsolt Bagyura; Loretta Kiss; Balázs Berta; Ágnes Szilágyi; Kristóf Hirschberg; Gábor Széplaki; Árpád Lux; Zsolt Szelid; Pál Soós; Béla Merkely
Journal:  BMC Cardiovasc Disord       Date:  2017-01-05       Impact factor: 2.298

2.  Association between VEGF Gene Polymorphisms and In-Stent Restenosis after Coronary Intervention Treated with Bare Metal Stent.

Authors:  Zsolt Bagyura; Loretta Kiss; Kristóf Hirschberg; Balázs Berta; Gábor Széplaki; Árpád Lux; Zsolt Szelid; Pál Soós; Béla Merkely
Journal:  Dis Markers       Date:  2017-03-07       Impact factor: 3.434
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.